Expression of Ki-67 and CD34 on blood and bone marrow cells of CML patients with different response to imatinib and nilotinib therapy.

T Perekhrestenko,U Melnyk,N Goryainova,I Diagil

Experimental oncology（2020）

引用 0|浏览2

暂无评分

摘要

Ki-67 expression and CD34 cell count in PB and BM of CML patients increased with the acquisition of clonal resistance to IM and NI. NI provides a deeper molecular response compared with IM.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要